Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2021

01-11-2021 | Esophagus Resection | ASO Author Reflections

ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?

Authors: Zhichao Liu, MD, PhD, Jianqiang Zhao, MD, PhD, Zhigang Li, MD, PhD

Published in: Annals of Surgical Oncology | Issue 12/2021

Login to get access

Excerpt

Endoscopic resection (ER) is widely accepted for the treatment of early esophageal squamous cell carcinoma (ESCC). Although ER is performed with curative intent, curative ER is not always possible. ER of an early ESCC can be noncurative when pejorative histopathological factors indicate a risk of nodal involvement (presence of submucosal invasion, lymphovascular invasion [LVI], and poor tumor differentiation) and incomplete resection (presence of positive resection margins). Currently, additional esophagectomy is the standard therapy after ER with noncurative factors, but the outcomes and beneficiaries of additional surgery remain unclear.1,2 Therefore, the indications for additional treatment after ER deserves further investigation to develop the optimal post-ER management. …
Literature
1.
Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Nat Compreh Cancer Netw. 2019;17(7):855–83.CrossRef
2.
Tsou YK, Lee CH, Le PH, Chen BH. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review. Crit Rev Oncol Hematol. 2020;147:102883.CrossRef
3.
4.
Dermine S, Leconte M, Leblanc S, et al. Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer. Therap Adv Gastroenterol. 2019;12:1756284819892556.CrossRef
5.
Saeki H, Watanabe M, Mine S, et al. Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection. J Gastroenterol. Apr 2015;50(4):406–13.CrossRef
Metadata
Title
ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
Authors
Zhichao Liu, MD, PhD
Jianqiang Zhao, MD, PhD
Zhigang Li, MD, PhD
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 12/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10473-5

Other articles of this Issue 12/2021

Annals of Surgical Oncology 12/2021 Go to the issue

Head and Neck Oncology

The Changing Demographics and Treatment of Larynx Cancer

Sarcoma

Staging and Surveillance of Myxoid Liposarcoma: Follow-up Assessment and the Metastatic Pattern of 169 Patients Suggests Inadequacy of Current Practice Standards

ASO Author Reflections

ASO Author Reflections: Multimodality Treatment in Anaplastic Thyroid Cancer: Improving Survival Outcomes and Balancing Treatment Related Complications

ASO Author Reflections

ASO Author Reflections: Oncologic Outcome of Endoscopic-Assisted Breast Surgery Compared with the Conventional Approach in Breast Cancers

ASO Author Reflections

ASO Author Reflections: The Central Role of Chemotherapy in Patients with Advanced Cancer Recently Diagnosed with Malignant Bowel Obstruction

Gastrointestinal Oncology

Fibrinogen-Albumin Ratio as a New Promising Preoperative Biochemical Marker for Predicting Oncological Outcomes in Gastric Cancer: A Multi-institutional Study